SEC Form 4 · accession 0001513162-15-000558
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Sep 17, 2015
Accepted (ET)
Sep 21, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 17, 2015 | P | 281 | $5.90 | A | 488,221 | D | |
| Common Stock | Sep 18, 2015 | P | 400 | $4.85 | A | 488,621 | D |
Table II — derivative securities
No Table II lines on this filing.